ArticleGenome medicine2026
Malaria-MOI: A flexible and scalable tool for predicting multiplicity of infection in malaria parasites.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundEstimating the multiplicity of infection (MOI) is critical for understanding malaria transmission dynamics and within-host Plasmodium parasite diversity. We developed Malaria-MOI, a fast, flexible, and species-agnostic Python tool that infers MOI directly from standard genomics files (e.g., BAM, VCF format) derived from whole genome sequencing (WGS), without requiring prior training data, curated panels or complex parameter tuning.
resultsWhen benchmarked on 27 Plasmodium falciparum mixed-clone samples with known MOI, Malaria-MOI matched or outperformed leading methods, achieving a root mean squared error of 0.38, mean absolute error of 0.15, and a correlation of 0.78 using genomic variants across 165 diverse loci. These results exceeded the median performance of existing Bayesian and likelihood-based approaches. Applied to 8,208 P. falciparum field samples, Malaria-MOI showed a strong negative correlation with FWS (ρ = − 0.76), consistent with its accurate capture of within-host diversity. It demonstrated high sensitivity for detecting monoclonal infections (0.99) and superior specificity (0.76) compared to estMOI (0.58), particularly at lower sequencing coverage. The tool also identified regional MOI differences aligned with transmission intensity, detecting more polyclonal infections in high-transmission areas such as West Africa, where estMOI underestimated complexity.
conclusionsOverall, Malaria-MOI accommodates diverse input types, including whole-genome data and diversity loci, and is compatible with both Illumina and Nanopore sequencing platforms. It is integrated into the Malaria-Profiler framework and is well-suited for genomic surveillance of Plasmodium and other pathogens, especially when elucidating transmission intensity for disease elimination activities. SOFTWARE: https://github.com/LSHTMPathogenSeqLab/Malaria-MOI .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.